Clinical trials in Bowling Green, KY

13 recruiting studies have a site in or near Bowling Green, KY, Kentucky.

Top conditions here

All conditions

Showing 13 of 13 studies

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Bowling Green, KY · Lexington, KY · Versailles, KY · +270 more sites

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Bowling Green, KY · Lexington, KY · Owensboro, KY · +205 more sites

RecruitingPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Sponsor: Bristol-Myers Squibb

Bowling Green, KY · Louisville, KY · Owensboro, KY · +119 more sites

RecruitingPhase 3NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Sponsor: AstraZeneca

Bowling Green, KY · Owensboro, KY · +78 more sites

RecruitingPhase not listedNCT07543757

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Sponsor: Sequenom, Inc.

Bowling Green, KY · +6 more sites

RecruitingPhase 2NCT07449702

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Sponsor: Oruka Therapeutics, Inc.

Bowling Green, KY · +21 more sites

RecruitingPhase 3NCT07662213

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Bowling Green, KY · +63 more sites

RecruitingPhase 4NCT06857942

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Sponsor: Eli Lilly and Company

Bowling Green, KY · +38 more sites

RecruitingPhase 3NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Sponsor: GlaxoSmithKline

Bowling Green, KY · +41 more sites

RecruitingNot applicableNCT06843577

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Sponsor: Zona Health, Inc

Bowling Green, KY · +9 more sites

RecruitingPhase 1NCT06944925

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Sponsor: Bambusa Therapeutics

Bowling Green, KY · Owensboro, KY · +1 more sites

RecruitingNot applicableNCT06003634

OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)

Sponsor: The University of Texas Medical Branch, Galveston

Bowling Green, KY · Hazard, KY

RecruitingNot applicableNCT06336122

OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

Sponsor: The University of Texas Medical Branch, Galveston

Bowling Green, KY · Hazard, KY

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.